Register      Login
Microbiology Australia Microbiology Australia Society
Microbiology Australia, bringing Microbiologists together
RESEARCH ARTICLE

Revisiting biodiscovery from microbial sources in the light of molecular advances

İpek Kurtböke
+ Author Affiliations
- Author Affiliations

GeneCology Research Centre and Faculty of Science, Health, Education and Engineering, University of the Sunshine Coast, Maroochydore DC, Qld 4558, Australia
Email: ikurtbok@usc.edu.au

Microbiology Australia 38(2) 58-61 https://doi.org/10.1071/MA17028
Published: 26 April 2017

Abstract

Since the discovery of penicillin microorganisms have been an unexhausted source of novel bioactive compounds that served as scaffolds for potential drug candidates as well for the development of new antibiotics via fermentative processes. However, after 30 glorious years of biodiscovery begun in the 1940s, discovery of new antibiotic or therapeutic compounds with medicinal value entered a decline phase from the late 1970s onwards. At the same time, significant increases in the numbers of antibiotic or multi-drug resistant bacteria resulting in serious infections were reported. Although natural product discovery research was encouraged to continue due to the need to treat these infections only a few discoveries of potent antibiotics were made in the years of decline such as the discovery of Nikkomycin and Spinosyn. However, at the dawn of the 21st century advances in molecular biology such as genome mining and metabolic engineering changed the scene providing new avenues to the field of drug discovery. This article will highlight some of these advances.


References

[1]  Zhang, H. et al. (2010) Complete biosynthesis of erythromycin A and designed analogs using E. coli as a heterologous host. Chem. Biol. 17, 1232–1240.
Complete biosynthesis of erythromycin A and designed analogs using E. coli as a heterologous host.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3cXhsVGntrfK&md5=4ad5d62623aa9b89499899c0e4b01b5eCAS |

[2]  Weber, T. et al. (2015)a antiSMASH 3.0—a comprehensive resource for the genome mining of biosynthetic gene clusters. Nucleic Acids Res. 43, W237–W243.
antiSMASH 3.0—a comprehensive resource for the genome mining of biosynthetic gene clusters.Crossref | GoogleScholarGoogle Scholar |

[3]  Weber, T. et al. (2015)b Metabolic engineering of antibiotic factories: new tools for antibiotic production in actinomycetes. Trends Biotechnol. 33, 15–26.
Metabolic engineering of antibiotic factories: new tools for antibiotic production in actinomycetes.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2cXitFCrtLzM&md5=d2eaa29f4d8e407bae73709d6715af09CAS |

[4]  Shen, B. (2015) A new golden age of natural products drug discovery. Cell 163, 1297–1300.
A new golden age of natural products drug discovery.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2MXhvFKksb%2FM&md5=2216def94e1026100b46122532206bc2CAS |

[5]  Traxler, M.F. and Kolter, R. (2015) Natural products in soil microbe interactions and evolution. Nat. Prod. Rep. 32, 956–970.
Natural products in soil microbe interactions and evolution.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2MXptVKgtL0%3D&md5=187d929457a54817eac9817a36bd1ecbCAS |

[6]  Cruz-Morales, P. et al. (2016) Phylogenomic analysis of natural products biosynthetic gene clusters allows discovery of arseno-organic metabolites in model streptomycetes. Genome Biol. Evol. 8, 1906–1916.
Phylogenomic analysis of natural products biosynthetic gene clusters allows discovery of arseno-organic metabolites in model streptomycetes.Crossref | GoogleScholarGoogle Scholar |

[7]  Medema, M.H. and Fischbach, M.A. (2015) Computational approaches to natural product discovery. Nat. Chem. Biol. 11, 639–648.
Computational approaches to natural product discovery.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2MXhtlKntrjP&md5=25e832085ae4ab214e576a481b00888dCAS |

[8]  Hadjithomas, M. et al. (2015) IMG-ABC: a knowledge base to fuel discovery of biosynthetic gene clusters and novel secondary metabolites. MBio 6, e00932-15.
IMG-ABC: a knowledge base to fuel discovery of biosynthetic gene clusters and novel secondary metabolites.Crossref | GoogleScholarGoogle Scholar |

[9]  Medema, M.H. et al. (2015) Minimum information about a biosynthetic gene cluster. Nat. Chem. Biol. 11, 625–631.
Minimum information about a biosynthetic gene cluster.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2MXhtlKntrjN&md5=ca7ed18c4c60ea08a3bb9f8eb0ceb4f1CAS |

[10]  Kalaitzis, J.A. et al. (2016) Genome-guided discovery of natural products and biosynthetic pathways from Australia’s untapped microbial megadiversity. Aust. J. Chem. 69, 129–135.
Genome-guided discovery of natural products and biosynthetic pathways from Australia’s untapped microbial megadiversity.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC28XitF2nu78%3D&md5=cce1d6a7b1109c3935211bb3d773b1eaCAS |

[11]  Mohimani, H. et al. (2014) NRPquest: coupling mass spectrometry and genome mining for nonribosomal peptide discovery. J. Nat. Prod. 77, 1902–1909.
NRPquest: coupling mass spectrometry and genome mining for nonribosomal peptide discovery.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2cXhtlalu7bO&md5=2eca6a937d8678992d0aa7186aaa7450CAS |

[12]  Choi, S.S. et al. (2015) Genome mining of rare actinomycetes and cryptic pathway awakening. Process Biochem. 50, 1184–1193.
Genome mining of rare actinomycetes and cryptic pathway awakening.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2MXnvFShsLg%3D&md5=db339d907e1309cbf0b6dfd1a7983014CAS |

[13]  Aigle, B. et al. (2014) Stambomycin and derivatives, their production and their uses as drugs. U.S. Patent 8,664,186.

[14]  Ochi, K. and Hosaka, T. (2013) New strategies for drug discovery: activation of silent or weakly expressed microbial gene clusters. Appl. Microbiol. Biotechnol. 97, 87–98.
New strategies for drug discovery: activation of silent or weakly expressed microbial gene clusters.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3sXjtlGhtQ%3D%3D&md5=9da4e84fc6409b838e1ad15955ebf4b6CAS |

[15]  Kawai, K. et al. (2007) The rare earth, scandium, causes antibiotic overproduction in Streptomyces spp. FEMS Microbiol. Lett. 274, 311–315.
The rare earth, scandium, causes antibiotic overproduction in Streptomyces spp.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD2sXhtVaisLfL&md5=ffa69b60b90d9c7956bdb0d1d29e914eCAS |

[16]  Inaoka, T. and Ochi, K. (2011) Scandium stimulates the production of amylase and bacilysin in Bacillus subtilis. Appl. Environ. Microbiol. 77, 8181–8183.
Scandium stimulates the production of amylase and bacilysin in Bacillus subtilis.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3MXhs1Gqt77L&md5=4279eead594242d4cb82f58cfc884153CAS |

[17]  Rutledge, P.J. and Challis, G.L. (2015) Discovery of microbial natural products by activation of silent biosynthetic gene clusters. Nat. Rev. Microbiol. 13, 509–523.
Discovery of microbial natural products by activation of silent biosynthetic gene clusters.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2MXhtFaitr3O&md5=b2064896126d3b1be63b3d05b922ec45CAS |

[18]  Gubbens, J. et al. (2014) Natural product proteomining, a quantitative proteomics platform, allows rapid discovery of biosynthetic gene clusters for different classes of natural products. Chem. Biol. 21, 707–718.
Natural product proteomining, a quantitative proteomics platform, allows rapid discovery of biosynthetic gene clusters for different classes of natural products.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2cXnslGntbs%3D&md5=e973bf74fdc51a3bc75846fa96cdb102CAS |

[19]  Bose, U. et al. (2017) Production of N-acyl homoserine lactones by the sponge-associated marine actinobacteria Salinispora arenicola and Salinispora pacifica. FEMS Microbiol. Lett. 364, fnx002.
Production of N-acyl homoserine lactones by the sponge-associated marine actinobacteria Salinispora arenicola and Salinispora pacifica.Crossref | GoogleScholarGoogle Scholar |

[20]  Camp, D. et al. (2012) Drug-like properties: guiding principles for the design of natural product libraries. J. Nat. Prod. 75, 72–81.
Drug-like properties: guiding principles for the design of natural product libraries.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3MXhs12hsb7N&md5=9b030f8ea60c85255f19592e39aed69bCAS |

[21]  Romero, C.A. et al. (2015) NMR fingerprints, an integrated approach to uncover the unique components of the drug-like natural product metabolome of termite gut-associated Streptomyces species. RSC Advances 5, 104 524–104 534.
NMR fingerprints, an integrated approach to uncover the unique components of the drug-like natural product metabolome of termite gut-associated Streptomyces species.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2MXhvFajs73K&md5=e42791896efa34baafb3c2ca7f2b3466CAS |

[22]  Esquenazi, E. et al. (2009) Imaging mass spectrometry of natural products. Nat. Prod. Rep. 26, 1521–1534.
Imaging mass spectrometry of natural products.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1MXhsVCjt7bE&md5=cd03898b1ee0b1e48b800513eb19fcbeCAS |

[23]  Yang, J.Y. et al. (2012) Primer on agar-based microbial imaging mass spectrometry. J. Bacteriol. 194, 6023–6028.
Primer on agar-based microbial imaging mass spectrometry.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38Xhs1Cju7zF&md5=b79e011798955d279b61dd2445fb6dddCAS |

[24]  Bode, H.B. et al. (2002) Big effects from small changes: possible ways to explore nature’s chemical diversity. ChemBioChem 3, 619–627.
Big effects from small changes: possible ways to explore nature’s chemical diversity.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD38Xlt1Kmtb0%3D&md5=1cf8f183454745eb87cefca847fe3041CAS |

[25]  English, A.L. et al. (2016) Evaluation of fermentation conditions triggering increased antibacterial activity from a near-shore marine intertidal environment-associated Streptomyces species. Synthetic and Systems Biotechnology , .
Evaluation of fermentation conditions triggering increased antibacterial activity from a near-shore marine intertidal environment-associated Streptomyces species.Crossref | GoogleScholarGoogle Scholar |

[26]  Thomas, T. et al. (2012) Metagenomics-a guide from sampling to data analysis. Microb. Inform. Exp. 2, 3.
Metagenomics-a guide from sampling to data analysis.Crossref | GoogleScholarGoogle Scholar |

[27]  Zotchev, S.B. et al. (2016) Metagenomics of marine actinomycetes: from functional gene diversity to biodiscovery. In: Marine OMICS: Principles and Applications (Kim, S.-K., Ed.). pp. 165–186. CRC Press.

[28]  Wilmes, P. and Bond, P.L. (2006) Metaproteomics: studying functional gene expression in microbial ecosystems. Trends Microbiol. 14, 92–97.
Metaproteomics: studying functional gene expression in microbial ecosystems.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD28XhtlGjt7o%3D&md5=bc9b8b8c9d0145bcd8dcd31f56a91448CAS |

[29]  Gilbert, J.A. et al. (2008) Detection of large numbers of novel sequences in the metatranscriptomes of complex marine microbial communities. PLoS One 3, e3042.
Detection of large numbers of novel sequences in the metatranscriptomes of complex marine microbial communities.Crossref | GoogleScholarGoogle Scholar |

[30]  Stepanauskas, R. (2012) Single cell genomics: an individual look at microbes. Curr. Opin. Microbiol. 15, 613–620.
Single cell genomics: an individual look at microbes.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38XhsVemtLvN&md5=cb12bc4121fbc2b4170d5603ffd37f85CAS |

[31]  Wilson, M.C. et al. (2014) An environmental bacterial taxon with a large and distinct metabolic repertoire. Nature 506, 58–62.
An environmental bacterial taxon with a large and distinct metabolic repertoire.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2cXhsl2hsL0%3D&md5=ca715a0d21393e841de9f66d450d7adcCAS |

[32]  Temperton, B. and Giovannoni, S.J. (2012) Metagenomics: microbial diversity through a scratched lens. Curr. Opin. Microbiol. 15, 605–612.
Metagenomics: microbial diversity through a scratched lens.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38XhtV2ms7%2FK&md5=fab19648441c7935af2233710ce30ff6CAS |

[33]  Kurtböke, D.I. (Ed.) (2003) Selective Isolation of Rare Actinomycetes. Queensland Complete Printing Services, Australia.

[34]  Kurtböke, D.I. (2011) Exploitation of phage battery in the search for bioactive actinomycetes. Appl. Microbiol. Biotechnol. 89, 931–937.
Exploitation of phage battery in the search for bioactive actinomycetes.Crossref | GoogleScholarGoogle Scholar |

[35]  Kurtböke, D.I. (2012) A phage-guided route to discovery of bioactive rare actinomycetes. in bacteriophages. InTech , 237–256.

[36]  Kurtböke, D.I. (2016) Actinomycetes in biodiscovery: genomic advances and new horizons. Chapter 35, pp. 567–590. In: The Handbook of Microbial Resources (Gupta, V.K., et al., Eds). CAB International Publications, Oxfordshire, UK.

[37]  Kurtböke, D.I. (Ed.) (2017) Microbial resources: from functional existence in nature to applications. Elsevier, in press.